PPT-Update in
Myeloproliferative Neoplasms January 20 2012 November 16 2011 FDA Indications for Ruxolitinib Jakafi Intermediate or highrisk Myelofibrosis 8090 of MF patients JAK2V617F
Download Presentation
Download Note : "Update in" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.